EUVIMEDEUVIMED entdecken
Crossref

Elucidation of the anti-gastric cancer mechanism of Guiqi Baizhu Formula by integrative approach of chemical bioinformatics

Yanru Wang, Jiawei Li, Xiuzhu Liu, Yixi Zhang, Chao Wang, Qingyang Guo, Yan Wang, Bing Jiang, Xiaojie Jin, Yongqi Liu

International Immunopharmacology · 2024-06 · 134 · 112245

DOI: 10.1016/j.intimp.2024.112245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Yanru Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Med…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Drugs, Chinese Herbal, Cell Proliferation, Apoptosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) has posed a great threat to the lives of people around the world. To date, safer and more cost-effective therapy for GC is lacking. Traditional Chinese medicine (TCM) may provide some new options for this. Guiqi Baizhu Formula (GQBZF), a classic TCM formula, has been extensively used to treat GC, while its bioactive components and therapeutic mechanisms remain unclear. In this study, we evaluated the underlying mechanisms of GQBZF in treating GC by integrative approach of chemical bioinformatics. GQBZF lyophilized powder (0.0625 mg/mL, 0.125 mg/mL) significantly attenuated the expression of p-IGF1R, PI3K, p-PDK1, p-VEGFR2 to inhibit the proliferation, migration and induce apoptosis of gastric cancer cells, which was consistent with the network pharmacology. Additionally, atractylenolide Ⅰ, quercetin, glycyrol, physcione and aloe-emodin, emodin, kaempferol, licoflavone A were found to be the key compounds of GQBZF regulating IGF1R and VEGFR2, respectively. And among which, glycyrol and emodin were determined as key active compounds against GC by farther vitro experiments and LC/MS. Meanwhile, we also found that glycyrol inhibited MKN-45 cells proliferation and enhanced apoptosis, which might be related to the inhibition of IGF1R/PI3K/PDK1, and emodin could significantly attenuate the MKN-45 cells migration, which might be related to the inhibition of VEGFR2-related signaling pathway. These results were verified again by molecular dynamics simulation and binding interaction pattern. In summary, this study suggested that GQBZF and its key active components (glycyrol and emodin) can suppress IGF1R/PI3K/PDK1 and VEGFR2-related signaling pathway, thereby inhibiting tumor cell proliferation and migration and inducing apoptosis. These findings provided an important strategy for developing new agents and facilitated clinical use of GQBZF against GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsDrugs, Chinese HerbalCell ProliferationApoptosisCell MovementReceptor, IGF Type 1Vascular Endothelial Growth Factor Receptor-2Computational BiologyHumansCell Line, TumorSignal TransductionPyruvate Dehydrogenase Acetyl-Transferring KinasePhosphatidylinositol 3-KinasesReceptors, SomatomedinNetwork PharmacologyAntineoplastic Agents, Phytogenic

Stichwörter der Autor:innen

EmodinGastric cancerGlycyrolGuiqi Baizhu FormulaIGF1R/PI3K/PDK1VEGFR2

Substanzen

Drugs, Chinese HerbalReceptor, IGF Type 1Vascular Endothelial Growth Factor Receptor-2KDR protein, humanIGF1R protein, humanPDK1 protein, humanPyruvate Dehydrogenase Acetyl-Transferring KinasePhosphatidylinositol 3-KinasesReceptors, SomatomedinAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou 730000, China.
  • College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.
  • College of Medical, Shanxi Datong University, Datong 037000, China.
  • Gansu University of Chinese Medicine, Lanzhou 730000, China.
  • Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou 730000, China; College of Pharmacy, Gansu University of…
  • Gansu University Key Laboratory for Molecular Medicine & Chinese Medicine Prevention and Treatment of Major Diseases, Gansu University of Chinese Medicine, Lanzhou 730000, China; Key Laboratory of Dunhuang Medical and T…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Li, J., Liu, X., Zhang, Y., Wang, C., Guo, Q., Wang, Y., Jiang, B., Jin, X., & Liu, Y. (2024). Elucidation of the anti-gastric cancer mechanism of Guiqi Baizhu Formula by integrative approach of chemical bioinformatics. International Immunopharmacology, 134, 112245. https://doi.org/10.1016/j.intimp.2024.112245

Vancouver

Wang Y, Li J, Liu X, Zhang Y, Wang C, Guo Q, et al. Elucidation of the anti-gastric cancer mechanism of Guiqi Baizhu Formula by integrative approach of chemical bioinformatics. International Immunopharmacology. 2024;134:112245. doi:10.1016/j.intimp.2024.112245

BibTeX
@article{Wang2024,
  author = {Wang, Yanru and Li, Jiawei and Liu, Xiuzhu and Zhang, Yixi and Wang, Chao and Guo, Qingyang and Wang, Yan and Jiang, Bing and Jin, Xiaojie and Liu, Yongqi},
  title = {Elucidation of the anti-gastric cancer mechanism of Guiqi Baizhu Formula by integrative approach of chemical bioinformatics},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {134},
  pages = {112245},
  doi = {10.1016/j.intimp.2024.112245}
}
Kostenlos starten →